ANZTPA.org
is available for sale
Hear how it ANZTPA.org sounds
About ANZTPA.org
ANZTPA is the former domain of the Australia New Zealand Therapeutic Product Agency. This joint scheme between Australia and New Zealand was in charge of regulating therapeutic products.
Exclusively on Odys Marketplace
€1,920
What's included:
Domain name ANZTPA.org
Become the new owner of the domain in less than 24 hours.
Complimentary Logo Design
Save time hiring a designer by using the existing high resolution original artwork, provided for free by Odys Global with your purchase.
Built-In SEO
Save tens of thousands of dollars and hundreds of hours of outreach by tapping into the existing authority backlink profile of the domain.
Free Ownership Transfer
Tech Expert Consulting
100% Secure Payments
Premium Aged Domain Value
Seen In
Age
Traffic
SEO Metrics
Own this Domain in 3 Easy Steps
With Odys, buying domains is easy and safe. Your dream domain is just a few clicks away.
.1
Buy your Favorite Domain
Choose the domain you want, add it to your cart, and pay with your preferred method.
.2
Transfer it to your Registrar
Follow our instructions to transfer ownership from the current registrar to you.
.3
Get your Brand Assets
Download the available logos and brand assets and start building your dream website.
Trusted by the Top SEO Experts and Entrepreneurs
Rachel Parisi
★ ★ ★ ★ ★
I purchased another three aged domains from Odys in a seamless and painless transaction. John at Odys was super helpful! Odys is my only source for aged domains —you can trust their product.
Stefan
★ ★ ★ ★ ★
Odys is absolutely the best premium domain marketplace in the whole internet space. You will not go wrong with them.
Adam Smith
★ ★ ★ ★ ★
Great domains. Great to deal with. In this arena peace of mind can be difficult to come by, but I always have it with Odys and will continue to use them and recommend them to colleagues and clients.
Brett Helling
★ ★ ★ ★ ★
Great company. Very professional setup, communication, and workflows. I will definitely do business with Odys Global moving forward.
Larrian Gillespie Csi
★ ★ ★ ★ ★
I have bought 2 sites from Odys Global and they have both been of high quality with great backlinks. I have used one as the basis for creating a new site with a great DR and the other is a redirect with again high DR backlinks. Other sites I have looked through have low quality backlinks, mostly spam. I highly recommend this company for reliable sites.
Henry Fox
★ ★ ★ ★ ★
Great company!
Vijai Chandrasekaran
★ ★ ★ ★ ★
I’ve bought over 30 domains from Odys Global in the last two years and I was always very satisfied. Besides great quality, niche-specific auction domains, Alex also helped me a lot with SEO and marketing strategies. Auction domains are not cheap, but quality comes with a price. If you have the budget and a working strategy, these domains will make you serious money.
Keith
★ ★ ★ ★ ★
Earlier this year, I purchased an aged domain from Odys as part of a promo they’re running at the time. It was my first experience with buying an aged domain so I wanted to keep my spend low. I ended up getting a mid level DR domain for a good price. The domain had solid links from niche relevant high authority websites. I used the site as a 301 redirect to a blog I had recently started. Within a few weeks I enjoyed new traffic levels on my existing site. Happy to say that the Odys staff are friendly and helpful and they run a great business that is respected within the industry.
ANZTPA: Description of a possible joint regulatory scheme for therapeutic products under ANZTPA
Consultation documents
Invitation to comment
Timetable
About the consultation
Background
Content of submissions
How to respond
What will happen
Confidentiality
Enquiries
Consultation documents
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Description of a possible joint regulatory framework under ANZTPA
Consultation document in PDF - 372kb
Consultation document in Word - 115kb
Invitation to comment
The TGA and Medsafe are seeking comments and input from interested parties on a discussion paper setting out the high level features of a possible framework for regulation of therapeutic products within the ANZTPA-a joint scheme to regulate therapeutic products in Australia and New Zealand.
Timetable
Document released for consultation on 8 January 2013. Interested parties should respond by close of business 21 February 2013 Feedback will be released following consideration of submissions. (see 'What will happen').
About the consultation
This discussion/information paper outlines a high level description of a possible joint regulatory scheme for therapeutic products under ANZTPA.
Through the consultation process, the TGA and Medsafe are requesting comment that will help to direct future work on the development of the regulatory framework for ANZTPA.
Content of submissions
Submissions may address any, or all, of the proposed amendments to the Description of a possible joint regulatory scheme for therapeutic products under ANZTPA or other identified issues.
In addition, submissions might include:
Suggested improvements
Whether or not you support the possible framework. If you do not support the possible framework as described, you may make suggestions for an alternative acceptable to you.
An assessment of how the proposed change will impact on you. That is, what do you see as the likely benefits or costs to you (these may be financial or non-financial). If possible, please attempt to quantify these costs and benefits.
Are there any areas where early harmonisation of processes between TGA and Medsafe would assist your business? Please list details of potential benefits for your business?
How to respond
All submissions should be accompanied by an ANZTPA consultation submission coversheet. This is available in Microsoft Word format - 29kb or Adobe PDF format - 20kb. Submissions must include full personal or organizational contact details (including address, telephone number and email).
Electronic submissions are preferred which should be emailed to [email protected] including 'ANZTPA - Possible joint regulatory scheme' in the subject line of the email.
Alternatively, hard copy submissions may be mailed to:
ANZTPA Therapeutic Goods Administration PO Box 100 WODEN ACT 2606
What will happen
Submissions will be reviewed by the TGA and Medsafe and feedback on submissions will be provided through the ANZTPA Internet site.
Input and comment on the possible key features of the framework will be used to help inform Australian and New Zealand government decisions on the development of the common regulatory framework for use by ANZTPA.
As the project progresses and more details of the framework are developed you will have the opportunity to provide feedback.
Confidentiality
All submissions will be placed on the ANZTPA website unless marked confidential. Any confidential material contained within your submission should be provided under a separate cover and clearly marked 'IN CONFIDENCE'. Reasons for a claim to confidentiality must be included in the space provided on the submission coversheet.
For submissions made by individuals, all personal details other than your name will be removed from your submission before it is published on the ANZTPA's website.
In addition, a list of parties making submissions will be published. If you do not wish to be identified with your submission you must specifically request this in the space provided on the submission coversheet.
Enquiries
Any questions relating to submissions should be directed to ANZTPA by email to [email protected]